Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Nanomedicine. 2011 Jun 15;8(2):212–220. doi: 10.1016/j.nano.2011.06.002

Figure 4.

Figure 4

A human pancreatic cancer cell line, MiaPaca-2, was used for xenograft establishment on nude mice. 7 days after the inoculation when palpable subcutaneous tumors were detected, the treatments were started in a similar manner to that with PANC-1 xenografts. A) Average body weights are shown. B) The average tumor volumes are shown as means ± SD. C) Images of representative nude mice with subcutaneous tumors at the last day of experiment are shown.